Building Blocks Catalog

300 Thousand compounds in stock

Original and unique

Make-on-demand
Building Blocks

1B novel building blocks

Reliable supply

Custom Synthesis

Over 650 highly skillful chemists

Unique synthesis technologies

Library Synthesis

48B Billion REAL compounds and

Custom Library Synthesis

FTE Chemistry Support

On site access to all Enamine stock BB’s

Highly flexible arrangements

2 000 new building blocks are synthesized monthly. Here is an important update to our MedChem Highlights from March 2024

Recent News

  • 11 April 2024   Press Release

    Metrion Biosciences enhances High Throughput Screening services with access ...

    Cambridge, UK and Kyiv, Ukraine, 11 April 2024: Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.

  • 27 March 2024   Press Release

    Enamine Announces Expansion of Its Library Synthesis Capabilities

    March, 2024, Kyiv, Ukraine. Enamine Ltd, the global leader in supplying small molecules and early drug discovery services, announces the expansion of its library synthesis capabilities with a focus on Enamine REAL compounds to further support the growing demands of agricultural and pharmaceutical companies, research institutes, and drug discovery centers.

  • 01 March 2024   News

    Enamine and Genez International Announce Strategic Collaboration to Launch ...

    We are excited to announce a strategic collaboration between Enamine, the world's leading provider of chemical building blocks, compound libraries, and biology services, and Genez International, a prominent enterprise with 15 years of experience in cross-border supply management, biopharmaceutical research and development, semiconductor equipment, and high-definition digital imaging systems.

Upcoming events

We are excited to co-author a new article published in the journal Science: “Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor”, resulting from a fruitful international collaboration involving:

  • Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
  • Graduate Program in Biophysics, University of California, San Francisco, San Francisco, CA, USA. 
  • Kobilka Institute of Innovative Drug Discovery, School of Life and Health Sciences, Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.
  • Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91058 Erlangen, Germany.
  • Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.
  • Enamine Ltd., 02094 Kyiv, Ukraine.
  • Institute of Bioorganic Chemistry and Petrochemistry, National Ukrainian Academy of Science, 02660 Kyiv, Ukraine.
  • National Taras Shevchenko University of Kyiv, 01601 Kyiv, Ukraine.
  • Chemspace, Riga LV-1082, Latvia.
  • National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP), School of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.
  • Department of Anatomy, University of California, San Francisco, San Francisco, CA, USA.

 

The article reports on discovering novel nonopioid analgesics from 301M REAL molecules in the ZINC15 library. A large-scale docking of virtual molecules to the α2A-adrenergic receptor binding site, followed by structure determination and studies in the lab, led to the identification of selective agonists that showed nanomolar activity without a sedative effect.

 

Many thanks to our colleague Dr. Natalia Tolmachova for representing Enamine in this study and to all the great collaborators: 

Yurii Moroz, Elissa Fink, Jun Xu, Hübner Harald, Joao Braz, Philipp Seemann, Charlotte Avet, Veronica Craik, Dorothee Weikert, Maximilian F. Schmidt, , Chase Webb, Xi-Ping Huang, Chakrapani Kalyanaraman, Stefan Gahbauer, Ph.D., Geng Chen, Zheng Liu, Matthew P. Jacobson, John Irwin, Michel Bouvier, Yang Du, Brian Shoichet, Allan Basbaum, Peter Gmeiner

 

Get more information about REAL compounds by Enamine here: https://enamine.net/compound-collections/real-compounds/real-space-navigator  

FOLLOW US